EUR 10.05
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -1.33 EUR | -515.63% |
2022 | 0.32 EUR | 464.88% |
2021 | -0.09 EUR | 37.36% |
2020 | -0.14 EUR | 50.0% |
2019 | -0.28 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.08 EUR | 109.08% |
2023 Q2 | -0.42 EUR | -1157.93% |
2023 Q4 | -0.93 EUR | -121.43% |
2023 FY | - EUR | -515.63% |
2022 Q2 | 0.28 EUR | 64.71% |
2022 FY | - EUR | 464.88% |
2022 Q4 | 0.04 EUR | -85.82% |
2021 FY | - EUR | 37.36% |
2021 Q4 | 0.17 EUR | 165.38% |
2021 Q2 | -0.26 EUR | 0.0% |
2020 FY | - EUR | 50.0% |
2019 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
MPH Health Care AG | 6.90 EUR | 119.275% |
Dermapharm Holding SE | 1.16 EUR | 214.655% |
Evotec SE | -0.47 EUR | -182.979% |
MERCK Kommanditgesellschaft auf Aktien | 6.50 EUR | 120.462% |
PharmaSGP Holding SE | 1.37 EUR | 197.08% |
SynBiotic SE | -2.24 EUR | 40.625% |